Suzy is responsible for managing and developing innovation and intellectual property for commercialisation as part of the Life Sciences team.
After learning commercialisation processes hands-on through leading a Warwick University spin-out company to exit, Suzy has served as a director of privately held therapeutic and pharma services companies and as CSO, then CEO of AIM-listed biotech ValiRx PLC. She has acted as business mentor across several commercialisation schemes, including through Innovate’s ICURe programme and through the Northern Triangle network. She currently also serves as a Trustee of the charity Leukaemia Care.
She holds PhD and BSc in Chemistry from Loughborough University.
Suzy joined Cambridge Enterprise in September 2025.